0001213900-22-080987.txt : 20221219
0001213900-22-080987.hdr.sgml : 20221219
20221219170834
ACCESSION NUMBER: 0001213900-22-080987
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221216
FILED AS OF DATE: 20221219
DATE AS OF CHANGE: 20221219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lemerond Nicole
CENTRAL INDEX KEY: 0001941712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39685
FILM NUMBER: 221471949
MAIL ADDRESS:
STREET 1: 3 MURRAY HILL ROAD
CITY: SCARSDALE
STATE: NY
ZIP: 10583
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001728328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
BUSINESS PHONE: (604) 669-7207
MAIL ADDRESS:
STREET 1: SUITE 310, 815 W. HASTINGS STREET
CITY: VANCOUVER
STATE: A1
ZIP: V6C 1B4
4
1
ownership.xml
X0306
4
2022-12-16
0
0001728328
InMed Pharmaceuticals Inc.
INM
0001941712
Lemerond Nicole
C/O INMED PHARMACEUTICALS INC.
310-815 WEST HASTINGS ST.
VANCOUVER
A1
V6C1B4
BRITISH COLUMBIA, CANADA
1
0
0
0
Employee Stock Option (Right to Buy)
1.78
2022-12-16
4
A
0
840
0.00
A
2027-12-15
Common shares
840
1400
D
The options were granted on 12/16/2022 and will vest as follows: Vesting 100% on the one-year anniversary of the grant date (Dec 16, 2023) or immediately prior to the next AGM, whichever is sooner.
On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split.
/s/ Eric Adams, attorney-in-fact for Ms. Nicole Lemerond
2022-12-19